Synopsys is in a pronounced downtrend, with the stock down 33.5% over the past year, significantly underperforming the S&P 500, which gained 20.5% over the same period. The current price of $397.87 sits near the lower end of its 52-week range, at approximately 10% above the low of $366.00 and 35% below the high of $615.79, indicating that the stock is trading near its lows, which could represent a value opportunity or a falling knife depending on fundamental catalysts. The 1-year relative strength of -54.0% versus the S&P 500 underscores the severity of the underperformance, driven by post-earnings selloffs and broader tech sector rotation.

Revenue growth has been robust, with the most recent quarter (Q2 FY2026, ended April 30, 2026) showing revenue of $2.276 billion, up 41.9% year-over-year, largely fueled by the Ansys acquisition. However, organic growth appears weaker, as highlighted by analysts, with the prior quarter (Q1 FY2026) revenue of $2.409 billion representing a sequential decline, and the company's net income of $17.1 million in Q2 was a sharp drop from $448.7 million in Q4 FY2025, reflecting integration costs and higher operating expenses. The revenue trajectory shows a spike from $1.604 billion in Q2 FY2025 to $2.276 billion in Q2 FY2026, but the sequential decline from Q1 FY2026 suggests that the acquisition boost may be fading, and investors are questioning the sustainability of growth.